Stealth BioTherapeutics Corp. (MITO) Stock Surging in Premarket, Here’s Why
Stealth BioTherapeutics Corp. (MITO), a clinical-stage biotechnology company, has surged 7.91% in the pre-market trading session. MITO stock is trading
Stealth BioTherapeutics Corp. (MITO), a clinical-stage biotechnology company, has surged 7.91% in the pre-market trading session. MITO stock is trading
Allogene Therapeutics, Inc. (ALLO), a clinical-stage immuno-oncology company, has dipped 32.73% and hence, ALLO stock was trading at $16.40 when
Vaxart, Inc. (VXRT), a clinical-stage biotechnology company, has soared 10.72% in aftermarket trading session. Consequently, VXRT stock is changing hands
Sundial Growers Inc. (SNDL), a company engaged in the production and marketing of cannabis products, has surged 16.74% in aftermarket
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.